Major Victory for Florida Patients: NACDS Hails Enactment of Florida Bill Holding PBMs Accountable
NACDS celebrates the enactment of a Florida bill holding PBMs accountable, marking a major victory for patients.
NACDS celebrates the enactment of a Florida bill holding PBMs accountable, marking a major victory for patients.
NACDS’ Principles of PBM Reform include “stopping the undercutting of reform laws” – as part of a comprehensive effort to end “pharmaceutical benefit manipulation” that harms patients, employers, taxpayers, communities, and pharmacies.
As Senate Finance Committee releases legislative framework, NACDS emphasizes its Principles of PBM Reform to ensure comprehensive and lasting solutions for patients, pharmacies, employers, taxpayers, communities, and the nation.
NACDS is lauding legislation introduced by U.S. Senators Peter Welch (D-VT) and Roger Marshall (R-KS) to crack down on tactics by which “pharmaceutical benefit manipulator” middlemen maximize profits at the expense of patients, pharmacies, and others.
NYRx puts patients over PBMs in the state’s Medicaid pharmacy benefit.
Statement defines specific solutions for patient-manipulation by “PBMs” and urges continued bipartisan work on this critical issue.
Last week, Health and Human Services (HHS) Secretary Xavier Becerra appeared before the U.S. Senate Appropriations Committee to provide testimony on the FY 2024 Funding Request and Budget Justification of the Department of Health and Human Services.
The Drug Price Transparency in Medicaid Act will protect patients, pharmacies, and others from middlemen tactics that drive up prescription drug prices.
NACDS President and CEO Steven C. Anderson released the following statement today following the introduction of pharmacy benefit manager (PBM) reform legislation (HB 1509/SB 1550) in the Florida legislature:
U.S. House Oversight and Accountability Committee expands bipartisan Congressional push to stop pharmaceutical benefit manipulation by middlemen.